Descriptor English: | Digoxin | ||||
Descriptor Spanish: |
Digoxina
| ||||
Descriptor Portuguese: | Digoxina | ||||
Descriptor French: | Digoxine | ||||
Entry term(s): |
Boehringer, Digoxina Digacin Digitek Digoregen Digoxina Boehringer Digoxine Nativelle Dilanacin Hemigoxine Nativelle Lanacordin Lanicor Lanoxicaps Lanoxin Lanoxin PG Lanoxin-PG Lenoxin Mapluxin Nativelle, Digoxine Nativelle, Hemigoxine |
||||
Tree number(s): |
D04.210.500.155.580.130.500.436 D04.210.500.155.580.130.688 D09.408.180.261.436 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004077 | ||||
Scope note: | A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) |
||||
Annotation: | do not confuse with DIGITOXIN |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Anti-Arrhythmia Agents Cardiotonic Agents Enzyme Inhibitors |
||||
Registry Number: | 73K4184T59 | ||||
CAS Type 1 Name: | Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- | ||||
DeCS ID: | 4116 | ||||
Unique ID: | D004077 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
Digoxin
- Preferred
Lanacordin
- Narrower
Lanicor
- Narrower
Lanoxicaps
- Narrower
Dilanacin
- Narrower
Digacin
- Narrower
Digitek
- Narrower
Digoregen
- Narrower
Digoxina Boehringer
- Narrower
Digoxine Nativelle
- Narrower
Mapluxin
- Narrower
Lanoxin
- Narrower
Concept UI |
M0006386 |
Scope note | A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) |
Preferred term | Digoxin |
Concept UI |
M0485081 |
Preferred term | Lanacordin |
Concept UI |
M0485080 |
Preferred term | Lanicor |
Concept UI |
M0372351 |
Preferred term | Lanoxicaps |
Concept UI |
M0372352 |
Preferred term | Dilanacin |
Concept UI |
M0485086 |
Preferred term | Digacin |
Concept UI |
M0485085 |
Preferred term | Digitek |
Concept UI |
M0485084 |
Preferred term | Digoregen |
Concept UI |
M0485083 |
Preferred term | Digoxina Boehringer |
Entry term(s) |
Boehringer, Digoxina |
Concept UI |
M0485082 |
Preferred term | Digoxine Nativelle |
Entry term(s) |
Hemigoxine Nativelle Nativelle, Digoxine Nativelle, Hemigoxine |
Concept UI |
M0485079 |
Preferred term | Mapluxin |
Concept UI |
M0006387 |
Preferred term | Lanoxin |
Entry term(s) |
Lanoxin PG Lanoxin-PG Lenoxin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey